HuidaGene Therapeutics Receives FDA Clearance for CRISPR/Cas13 RNA-Editing Therapy to Treat Age-Related Macular Degeneration Global clinical-stage biotech company HuidaGene Therapeutics…
Trending
- Crossroads Invests in SUD Expansion with Acquisition of Family Health Services
- House oversight panel scrutinizes organ transplant system
- Should You Panic When Your Server Doesn’t Write Anything Down?
- Democrat senators warn Medicaid cuts could worsen rural hospital cybersecurity
- Study highlights potentially dangerous e-cigarette modifications by youth, adults
- Amid PFAS Fallout, a Maine Doctor Navigates Medical Risks With Her Patients
- Chemical variations in prostate cancer calcifications analyzed to identify new diagnostic markers
- Breakthroughs Changing The Diagnosis And Treatment Of Alzheimer’s